About Optimum Therapeutics
Optimum Therapeutics is a company based in San Diego (United States) founded in 2008. Optimum Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter San Diego, United States
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Optimum Therapeutics Private Limited
- Date of Incorporation 13 Dec, 2011
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
$2.47 M (USD)-6.31as on Mar 31, 2023
-
Net Profit
$170.69 K (USD)-10.85as on Mar 31, 2023
-
EBITDA
$373.1 K (USD)0.32as on Mar 31, 2023
-
Latest Funding Round
$344.46 K (USD), Grant
Sep 08, 2012
-
Investors
NIH
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Optimum Therapeutics
Investors in Optimum Therapeutics
Optimum Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for Optimum Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Optimum Therapeutics
Investment portfolio details for Optimum Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Optimum Therapeutics
Detailed financials for Optimum Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Optimum Therapeutics Comparisons
Peer comparison for Optimum Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Optimum Therapeutics
Optimum Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| Locked | Locked | Locked |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and rare diseases are developed.
|
Detailed competitors of Optimum Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Optimum Therapeutics
Complete news archive for Optimum Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optimum Therapeutics
Optimum Therapeutics was founded in 2008.
Optimum Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Annual revenue of Optimum Therapeutics is $2.47M as on Mar 31, 2023.
Optimum Therapeutics discovers and develops therapeutics for the treatment of solid tumors by improving nanomedicine delivery and transport. The company has been awarded 9 grants from SBIR for a total value of 4.75M. Its lead candidate for bladder cancer is in Phase III. The next lead candidate is a Noncytotoxic chemosensitizer, in Phase II trials. It is also developing a drug candidate for Peritoneal Cancer, which is currently in preclinical stages.
Optimum Therapeutics's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.